Certain groups, like pregnant women, children, the elderly, and individuals with chronic health conditions, are more vulnerable and may experience complications or unusual symptoms
ALCAR has displayed mixed results in clinical trials
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become a leading weight loss medication used by millions of people seeking sustainable body composition changes
While Topamax alone is not FDA-approved for weight loss, it is a key component of the FDA-approved combination drug, Qsymia, which includes topiramate and phentermine, a prescription appetite suppressant
Some health insurance formularies cover Mounjaro, while others list it as a nonpreferred drug